Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration

Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration
genengnews.com

by Alex Philippidis • 1 month ago

Novo Nordisk and Valo Health have expanded their AI collaboration to a potential value of over $4.6 billion, aiming to develop up to 20 treatments for obesity, type 2 diabetes, and cardiovascular disease. This marks a significant increase from their initial partnership, which focused on 11 programs. The agreement includes a $190 million upfront payment and emphasizes the use of Valo's Opal Computational Platform to enhance drug discovery through human data insights.

Summarized in 80 words

Latest AI Tools

More Tech Bytes...